Early research (Phase 1)UnknownNCT04691765What this trial is testingAnakinra in Previously Untreated Chronic Lymphocytic Leukemia PatientsWho this might be right forChronic Lymphocytic Leukemia Dr. David Spaner 12
Large-scale testing (Phase 3)Study completedNCT01010061What this trial is testingCLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 787
Testing effectiveness (Phase 2)UnknownNCT00892827What this trial is testingCombined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic LeukemiaWho this might be right forAdvanced Refractory Chronic Lymphocytic Leukemia Wolfson Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00290810What this trial is testingBevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT01008462What this trial is testingAutologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaWho this might be right forB-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT04149821What this trial is testingUmbralisib Plus Ublituximab (U2) in Progressive CLL After Novel TherapyWho this might be right forChronic Lymphocytic LeukemiaCLL ProgressionCLL/SLL Weill Medical College of Cornell University 1
Testing effectiveness (Phase 2)WithdrawnNCT06839872What this trial is testingInvestigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma AstraZeneca
Early research (Phase 1)Study completedNCT01471067What this trial is testingCord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesWho this might be right forBlood And Marrow TransplantationLeukemiaLymphoma+2 more M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Study completedNCT02863718What this trial is testingIbrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease ProgressionWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 515
Large-scale testing (Phase 3)Looking for participantsNCT06943872What this trial is testingInvestigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeOne Medicines 630
Large-scale testing (Phase 3)Active Not RecruitingNCT04075292What this trial is testingStudy of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forUntreated Chronic Lymphocytic Leukemia AstraZeneca 155
Early research (Phase 1)Active Not RecruitingNCT03422393What this trial is testingVenetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent IbrutinibWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Michael Choi 24
Testing effectiveness (Phase 2)Looking for participantsNCT03516617What this trial is testingAcalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Mayo Clinic 120
Large-scale testing (Phase 3)Study completedNCT02980731What this trial is testingA Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).Who this might be right forChronic Lymphocytic Leukemia (CLL) AbbVie 210